Exelixis (EXEL) EBT Margin (QoQ) (2010 - 2026)

Exelixis (EXEL) EBT Margin (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 162.00
Jan 2, 2026 -2.00
Oct 3, 2025 168.00
Jul 4, 2025 352.00
Apr 4, 2025 443.00
Jan 3, 2025 392.00
Sep 27, 2024 -1,728.00
Jun 28, 2024 3,437.00
Mar 29, 2024 -990.00
Dec 29, 2023 2,025.00
Sep 29, 2023 -2,013.00
Jun 30, 2023 956.00
Mar 31, 2023 1,922.00
Dec 30, 2022 -2,977.00
Sep 30, 2022 125.00
Jul 1, 2022 -284.00
Oct 1, 2021 -1,621.00
Jul 2, 2021 3,317.00
Apr 2, 2021 6,674.00
Jan 1, 2021 -5,104.00